Factors | Group A (n = 12) | Group B (n = 12) | P value | |
Male/Female | 8/4 | 7/5 | 0.5000 | |
Age (years) | 65.1 (40 - 79) | 64.8 (33 - 78) | 0.5000 | |
Depth of cancer invasion |
|
|
| |
Mucosa | 50.0% (6/12) | 58.3% (7/12) | 0.5000 | |
Submucosa | 25.0% (3/12) | 25.0% (3/12) |
| |
Muscularis propria | 25.0% (3/12) | 16.7% (2/12) |
| |
Lymph node metastasis |
|
|
| |
No | 100% (12/12) | 100% (12/12) |
| |
Pathological stage |
|
|
| |
Stage IA | 75.0% (9/12) | 73.3% (10/12) | 0.5000 | |
Stage IB | 25.0% (3/12) | 26.7% (2/12) |
| |
Lymph node resection |
|
|
| |
D1 | 75.0% (9/12) | 73.3% (10/12) | 0.5000 | |
D1 + α | 25.0% (3/12) | 26.7% (2/12) |
| |
PHCV preservation |
|
|
| |
Preservation | 100% (12/12) | 100% (12/12) |
| |
No preservation | 0% (0/12) | 0% (0/12) |
| |
Resected stomach |
|
|
| |
2/3 | 100% (12/12) | 100% (12/12) |
| |
Length of antral cuff (mean ± SD cm) |
|
|
| |
3.1 ± 0.4 | 2.0 ± 0.5 | <0.0001 | ||
Past history |
|
|
| |
No | 100% (12/12) | 100% (12/12) |
| |
Postoperative complication |
|
|
| |
Wound infection | 0% (0/12) | 8.3% (1/12) | 0.5000 | |
Postoperative chemotherapy (6 months after operation) |
|
|
| |
No | 75.0% (9/12) | 83.3% (10/12) | 0.5000 |